Transactions

Royalty Pharma published press releases by date and/or category

Arteaus Therapeutics Sells Emgality Royalty for $260 Million

NEW YORK, April 1, 2019 – Royalty Pharma and Arteaus Therapeutics, a biotechnology development company co-founded by Atlas Venture and OrbiMed, announced today that Arteaus has sold its royalty interest on future global net sales of Eli Lilly and Company’s (NYSE: LLY) Emgality (galcanezumab), an

Stay up to date

Subscribe to Royalty Pharma news and alerts

Subscribe